Obiettivo
Objectives
: A specific limiting factor in designing genetically based intervention therapies is that the optimal target molecule or multi-molecular complex is not usually known for a given disease situation because very little information is available regarding the components involved in the control of gene expression and their mode of interaction in what is now known to be a very sophisticated spatial and temporal context within the nucleus. For this purpose most of the currently used methods are clearly insufficient as they rely on the permeabilisation of cells and the fractionation of nuclei which are likely to introduce important deviations from the actual native state in the dynamic, living cell. The participants therefore propose to use and further develop state of the art methods allowing the direct spatial and temporal visualisation of macromolecular interactions relevant to gene control in vivo.
At present gene intervention therapies aimed to delay or correct cell transformation have been significantly limited by several basic problems of gene function and regulation, which remain poorly understood. As a result, gene transfer technologies have failed to achieve a therapeutic value in the majority of cases. Clearly, more attention needs to be focused on basic questions about how cells utilise genetic information to mediate biological processes such as gene expression, replication, repair and recombination. A specific limiting factor in designing genetically based intervention therapies is that the optimal target molecule or multi-molecular complex is not usually known for a given disease situation because very little information is available regarding the components involved in the control of gene expression and their mode of interaction in what is now known to be a very sophisticated spatial and temporal context within the nucleus. For this purpose most of the currently used methods are clearly insufficient as they rely on the permeabilisation of cells and the fractionation of nuclei, which are likely to introduce important deviations from the actual native state in the dynamic, living cell.
We therefore propose to use and further develop state of the art methods allowing the direct spatial and temporal visualisation of macromolecular interactions relevant to gene control in vivo. This will lead to the development of a number of cellular and animal model systems which will not only provide greater insight into basic macromolecular interactions in vivo, but will also act as test systems for disease processes and the design of therapeutic strategies.
The stages of the proposal are:
1. The development of ultra high sensitive technology to detect a minimal number of fluorescent molecules in a single living cell;
2. The development and improvement of methods that allow an efficient delivery of antisense probes into cells (e.g. microinjection, electroporation, particle bombardment);
3. Construction of a cellular model that will allow the continuous assessment of the stage of the cell cycle by direct microscopic observation on a single, living cell basis and which may be used to study the interactions of genes predisposing to cancer;
4. The development of methods to visualise the biosynthesis of mRNA molecules in living cells and the extension of this approach to screen accessible target sites on nuclear RNA within an antisense oligonucleotide protocol;
5. Address issues regarding "chromatin ilexibility".
The mobility of genes in the nucleus will be determined throughout the cell cycle in order to assess the probability of collision between genes involved in translocations causing leukaemia. Novel information will also be provided for the design of optimal LCR-based expression vectors by identifying the minimal distance required between the LCR and the promoter of choice for maximum activation, using the human beta-globin gene locus as a model system in the first instance. Electron microscopic in situ hybridisation methods will be developed to visualise direct interactions between distantly located genetic control elements in particular LCRs and their cognate promoter(s). This technology will be developed using the globin LCR as a model system and then extended to localise the LCR within the human desmin gene domain. These objectives fit directly with area 4.1.4 of the Biomed 2 programme.
Keywords: transgenic mouse models; gene regulation; gene interactions; cell cycle; antisense oligonucleotides. 04 04
Campo scientifico (EuroSciVoc)
CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.
CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.
- scienze mediche e della salute biotecnologia medica ingegneria genetica terapia genica
- scienze naturali scienze biologiche genetica RNA
- scienze mediche e della salute medicina clinica oncologia leucemia
- scienze naturali scienze chimiche elettrochimica bioelettrochimica elettroporazione
È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione
Programma(i)
Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.
Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.
Argomento(i)
Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.
Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.
Invito a presentare proposte
Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.
Dati non disponibili
Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.
Meccanismo di finanziamento
Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.
Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.
Coordinatore
1649-028 LISBOA
Portogallo
I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.